VeriMomIst schizosaccharomyces pombe extract in der Schwangerschaft sicher?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were found for Schizosaccharomyces pombe extract. Literature (general PubMed records on S. pombe as a microbiological model) does not report reproductive or developmental toxicity from topical cosmetic use; cosmetic databases (CosIng/PubChem entries for yeast/ferment extracts) treat this as a topical/biotech-derived extract. Given lack of evidence for reproductive hazard and expected negligible dermal systemic absorption of large-biopolymer extracts, default scores are 0. Sources consulted: ECHA Annex VI (no listing), PubMed, CosIng, PubChem.
Pregnancy-safe products containing schizosaccharomyces pombe extract
Related ingredients
Frequently asked questions
- Ist schizosaccharomyces pombe extract in der Schwangerschaft sicher?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety flags were found for Schizosaccharomyces pombe extract. Literature (general PubMed records on S. pombe as a microbiological model) does not report reproductive or developmental toxicity from topical cosmetic use; cosmetic databases (CosIng/PubChem entries for yeast/ferment extracts) treat this as a topical/biotech-derived extract. Given lack of evidence for reproductive hazard and expected negligible dermal systemic absorption of large-biopolymer extracts, default scores are 0. Sources consulted: ECHA Annex VI (no listing), PubMed, CosIng, PubChem.
- Ist schizosaccharomyces pombe extract während des Stillens sicher?
- No data indicating reproductive or lactation-related toxicity or systemic exposure that would affect breastfed infants. Yeast/ferment extracts are not identified as lactation hazards in available cosmetic/regulatory sources; therefore hazard and mechanism scores are 0 and dermal exposure is considered negligible for typical topical cosmetic use.
- Ist schizosaccharomyces pombe extract sicher für Babyhaut?
- No infant-specific reproductive or developmental toxicity data were identified. Mechanism/hazard remain 0. Exposure score increased to 1 for 0–3 yr skin because infant skin has higher permeability and surface-area-to-weight, and although large biochemical extracts have low dermal bioavailability, neonatal barrier immaturity makes a low but measurable exposure plausible.
- Wie bewertet VeriMom schizosaccharomyces pombe extract?
- VeriMom bewertet schizosaccharomyces pombe extract mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu schizosaccharomyces pombe extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu schizosaccharomyces pombe extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.